
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES173
A post hoc analysis of the DALI trial286 showed that both standard and aggressive therapy with atorvastatin (1080 mg) did not reverse endothelial dysfunction (as measure by the surrogate marker of flow mediated vasodilatation). Level 1+

[@van_Venrooij_2002]

